A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo for Smoking Cessation
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the safety and efficacy of varenicline given
for a twelve week treatment period in comparison with placebo for smoking cessation.